Zheng Wei

发表

Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia

P. Liu, Jifeng Jiang, Zhao Xu, 2020, OncoTargets and therapy.

Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue—from (auto)antigen driven selection to the activation of NF-κB signaling

P. Liu, Jing Li, Zheng Wei, 2015, Science China Life Sciences.

The peripheral blood mononuclear cells versus purified CD34+ cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trial

W. Fu, Z. Dong, Zheng Wei, 2022, Stem cell research & therapy.

Three‐year outcomes of peripheral blood mononuclear cells vs purified CD34 + cells in the treatment of angiitis‐induced no‐option critical limb ischemia and a cost‐effectiveness assessment: A randomized single‐blinded noninferiority trial

P. Liu, W. Fu, Z. Dong, 2021, Stem cells translational medicine.

Purified CD34+ cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial

P. Liu, Zhenyu Shi, W. Fu, 2018, EBioMedicine.

A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.

P. Liu, Jing Li, Zheng Wei, 2017, Journal of thoracic disease.

HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China

Junmin Li, Yunfeng Cheng, Zheng Wei, 2014, Medical Oncology.

Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.

F. Mendelsohn, W. Fu, D. Guo, 2013, Journal of vascular surgery.

The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides

P. Liu, Tianhong Xu, Jing Li, 2020, Leukemia & lymphoma.

Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion

W. Fu, Z. Dong, Zheng Wei, 2022, Stem cells translational medicine.

Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia

W. Fu, Z. Dong, Zheng Wei, 2021, Frontiers in Cardiovascular Medicine.

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia

P. Liu, Zhenyu Shi, W. Fu, 2019, Stem Cell Research & Therapy.

A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia

P. Liu, Zhenyu Shi, W. Fu, 2018, Stem cells translational medicine.

Return to work after cell transplantation in patients with angiitis-induced critical limb ischaemia and factors related: a single-centre retrospective cohort study

W. Fu, Z. Dong, Zheng Wei, 2022, Stem Cell Research & Therapy.

Role of prophylactic radiotherapy in Chinese patients with primary testicular diffuse large B-cell lymphoma: a single retrospective study.

P. Liu, Jing Li, Zheng Wei, 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Histological Impact on Follicular Lymphoma Grade 3 Treated With Frontline RCHOP Regimen

Peng Liu, Lijuan Yuan, Zheng Wei, 2021 .

Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort study

P. Liu, Jing Li, Zheng Wei, 2020, BMJ Open.

Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia

Jifeng Jiang, Zhao Xu, Yifeng Sun, 2019, OncoTargets and therapy.

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience

P. Liu, W. Fu, D. Guo, 2020, Stem cell research & therapy.

A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective Study

Jing Li, P. Liu, Zheng Wei, 2018, BioMed research international.

Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China: a propensity-score matched multicenter study

Peng Liu, Jing Li, Q. Zhan, 2022, Annals of Hematology.

Single-Cell Transcriptomes Combining with Consecutive Genomics Reveal Clonal Evolution and Gene Regulatory Networks in Relapsed and Refractory Multiple Myeloma

Jifeng Jiang, Jing Li, Yifeng Sun, 2022, Frontiers in Cell and Developmental Biology.

miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1

Mingyu Liang, Yi Fang, Xiaoqiang Ding, 2017, Oxidative medicine and cellular longevity.

A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients

Peng Liu, Tianhong Xu, Lijuan Yuan, 2023, Clinical and experimental medicine.

Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord

P. Liu, H. Qiu, Zheng Wei, 2020, Bone Marrow Transplantation.

Monoclonal gammopathies regardless of subtypes are associated with poor prognosis of diffuse large B-cell lymphoma

Jing Li, P. Liu, Zheng Wei, 2018, Medicine.

Therapeutic efficacy of CD34+ cell-involved mononuclear cell therapy for no-option critical limb ischemia: A meta-analysis of randomized controlled clinical trials

W. Fu, Z. Dong, Zheng Wei, 2018, Vascular medicine.

Carotenoid intake and risk of non-Hodgkin lymphoma: a systematic review and dose-response meta-analysis of observational studies

Ping Liu, P. Liu, Jing Li, 2017, Annals of Hematology.

Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue—from (auto)antigen driven selection to the activation of NF-κB signaling

P. Liu, Jing Li, Zheng Wei, 2015, Science China Life Sciences.

Superagonistic CD28 Protects against Renal Ischemic Injury by Expansion of Regulatory T-Cell

Yi Fang, Xiaoqiang Ding, Yiran Liang, 2017, American Journal of Nephrology.

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia

Zhenyu Shi, W. Fu, D. Guo, 2019, Stem Cell Research & Therapy.

Real World Data on the Efficacy and Safety of Ixazomib Based Therapy in Multiple Myeloma: An Observational Study from China

Jing Li, Zheng Wei, Peng Liu, 2019, Clinical Lymphoma Myeloma and Leukemia.

Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up

T. Zhu, Ming Xu, R. Rong, 2020, Annals of translational medicine.

Induction tolerance with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with 10-year follow-up

T. Zhu, Ming Xu, R. Rong, 2020 .

Layer-specific strain in patients with cardiac amyloidosis using tissue tracking MR

Hang Jin, Zheng Wei, Cui-zhen Pan, 2023, Frontiers in radiology.